Explore more publications!
St. Vincent & Grenadines Health Press
Got News to Share?

St. Vincent & Grenadines Health Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on St. Vincent & Grenadines Health Press.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 9, 2025

Aradigm Launches First-of-Its-Kind Platform to Provide Sustainable Access to Life-Saving Cell and Gene Therapies
December 9, 2025

Aradigm Launches First-of-Its-Kind Platform to Provide Sustainable Access to Life-Saving Cell and Gene Therapies

Indeterminate GlobeNewswire
“The Heroism and Resiliency of 9/11” Documentary Selected for 2026 Central Florida Film Festival
December 9, 2025

“The Heroism and Resiliency of 9/11” Documentary Selected for 2026 Central Florida Film Festival

Indeterminate GlobeNewswire
The Therapy Group of Philadelphia Joins the Lumina Therapy Alliance, Expanding a National Network of Premium In-Person Mental Health Practices
December 9, 2025

The Therapy Group of Philadelphia Joins the Lumina Therapy Alliance, Expanding a National Network of Premium In-Person Mental Health Practices

Indeterminate GlobeNewswire
Olympia Pharmaceuticals and Wesley Pharmaceuticals Co-Founder Stan Loomis Establishes Scholarship for The Florida A&M University College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health
December 9, 2025

Olympia Pharmaceuticals and Wesley Pharmaceuticals Co-Founder Stan Loomis Establishes Scholarship for The Florida A&M University College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health

Indeterminate GlobeNewswire
Gelteq Signs Three Year Sales Agreement with Shenzhen Mana Health Management Co. Strengthening Gelteq’s Nutritional Product Expansion into China
December 9, 2025

Gelteq Signs Three Year Sales Agreement with Shenzhen Mana Health Management Co. Strengthening Gelteq’s Nutritional Product Expansion into China

Indeterminate GlobeNewswire
UPDATE -- Tessera Therapeutics Announces Chief Financial Officer (CFO) Transition and Appointment of Kathy Bergsteinsson as CFO
December 9, 2025

UPDATE -- Tessera Therapeutics Announces Chief Financial Officer (CFO) Transition and Appointment of Kathy Bergsteinsson as CFO

Indeterminate GlobeNewswire
Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion
December 9, 2025

Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion

Indeterminate GlobeNewswire
Myriad Genetics to Present 8 Abstracts about MRD and Other Studies at 2025 San Antonio Breast Cancer Symposium
December 9, 2025

Myriad Genetics to Present 8 Abstracts about MRD and Other Studies at 2025 San Antonio Breast Cancer Symposium

Indeterminate GlobeNewswire
Dandy Acquires Neem to Accelerate Digital Innovation in Dentistry
December 9, 2025

Dandy Acquires Neem to Accelerate Digital Innovation in Dentistry

Indeterminate GlobeNewswire
Alpha Tau Successfully Treats First Patient in its U.S. Trial for Patients with Recurrent Glioblastoma at the James Cancer Hospital at The Ohio State University
December 9, 2025

Alpha Tau Successfully Treats First Patient in its U.S. Trial for Patients with Recurrent Glioblastoma at the James Cancer Hospital at The Ohio State University

Indeterminate GlobeNewswire
Young Americans Lead in HSA Adoption But Carry Heaviest Economic Burden, HealthEquity Research Finds
December 9, 2025

Young Americans Lead in HSA Adoption But Carry Heaviest Economic Burden, HealthEquity Research Finds

Indeterminate GlobeNewswire
YD Bio Limited Showcases Its Innovative Diagnostic and Precision Medicine Portfolios at the 9th Healthcare EXPO TAIWAN
December 9, 2025

YD Bio Limited Showcases Its Innovative Diagnostic and Precision Medicine Portfolios at the 9th Healthcare EXPO TAIWAN

Indeterminate GlobeNewswire
Akari Therapeutics Highlights Preclinical Data Demonstrating Therapeutic Potential of Lead Candidate, AKTX-101, for Hard-to-Treat K-Ras Mutant Pancreatic Cancer
December 9, 2025

Akari Therapeutics Highlights Preclinical Data Demonstrating Therapeutic Potential of Lead Candidate, AKTX-101, for Hard-to-Treat K-Ras Mutant Pancreatic Cancer

Indeterminate GlobeNewswire
Cedar Gate Introduces Next-Generation Solutions for Prospective Bundled Payment Models
December 9, 2025

Cedar Gate Introduces Next-Generation Solutions for Prospective Bundled Payment Models

Indeterminate GlobeNewswire
Cannabix Marijuana Breath Test Clears Key Regulatory Milestone: Handheld Breath Collection Unit (BCU) Passes FCC Electronic Emissions Testing
December 9, 2025

Cannabix Marijuana Breath Test Clears Key Regulatory Milestone: Handheld Breath Collection Unit (BCU) Passes FCC Electronic Emissions Testing

Indeterminate GlobeNewswire
A.D.A.M. Innovations Announces the Launch of ALUNAÉ
December 9, 2025

A.D.A.M. Innovations Announces the Launch of ALUNAÉ

Indeterminate GlobeNewswire
STRATA Skin Sciences Showcases XTRAC® and TheraclearX® at TeraCILAD 2025 — Reports Early Adoption Momentum in Mexico
December 9, 2025

STRATA Skin Sciences Showcases XTRAC® and TheraclearX® at TeraCILAD 2025 — Reports Early Adoption Momentum in Mexico

Indeterminate GlobeNewswire
Moleculin Announces Completion of Treatment for the 45 Patients in Pivotal “MIRACLE” Phase 3 AML Trial on Pace for Q1 2026
December 9, 2025

Moleculin Announces Completion of Treatment for the 45 Patients in Pivotal “MIRACLE” Phase 3 AML Trial on Pace for Q1 2026

Indeterminate GlobeNewswire
Inspira Technologies Granted Patent in Japan for the INSPIRA™ ART System's Convertible Dual Lumen Cannula Device and Method of Use
December 9, 2025

Inspira Technologies Granted Patent in Japan for the INSPIRA™ ART System's Convertible Dual Lumen Cannula Device and Method of Use

Indeterminate GlobeNewswire
Celldex Initiates Global Registrational Phase 3 Program of Barzolvolimab in Cold Urticaria and Symptomatic Dermographism
December 9, 2025

Celldex Initiates Global Registrational Phase 3 Program of Barzolvolimab in Cold Urticaria and Symptomatic Dermographism

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions